The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
Open accessAbstract
BACKGROUND/AIMS: During development of liver fibrosis, an important source of myofibroblasts is hepatocytes, which differentiate into myofibroblasts by epithelial to mesenchymal transition (EMT). In epithelial tumours and kidney fibrosis, hypoxia, through activation of hypoxia-inducible factors (HIFs), is an important stimulus of EMT. Our recent studies demonstrated that HIF-1alpha is important for the development of liver fibrosis. Accordingly, the hypothesis was tested that hypoxia stimulates hepatocyte EMT by a HIF-dependent mechanism. METHODS: Primary mouse hepatocytes were exposed to room air or 1% oxygen and EMT evaluated. In addition, bile duct ligations (BDLs) were performed in control and HIF-1alpha-deficient mice and EMT quantified. RESULTS: Exposure of hepatocytes to 1% oxygen increased expression of alpha-smooth muscle actin, vimentin, Snail and fibroblast-specific protein-1 (FSP-1). Levels of E-cadherin and zona occludens-1 were decreased. Upregulation of FSP-1 and Snail by hypoxia was completely prevented in HIF-1beta-deficient hepatocytes and by pretreatment with SB431542, a transforming growth factor-beta (TGF-beta) receptor inhibitor. HIFs promoted TGF-beta-dependent EMT by stimulating activation of latent TGF-beta1. To determine whether HIF-1alpha contributes to EMT in the liver during the development of fibrosis, control and HIF-1alpha-deficient mice were subjected to BDL. FSP-1 was increased to a greater extent in the livers of control mice when compared with HIF-1alpha-deficient mice. CONCLUSIONS: Results from these studies demonstrate that hypoxia stimulates hepatocyte EMT by a HIF and TGF-beta-dependent mechanism. Furthermore, these studies suggest that HIF-1alpha is important for EMT in the liver during the development of fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The HIF pathway also indirectly promotes EMT through a number of cell signaling pathways, including Notch (74, 75), TGF-β (76), integrin-linked kinase (77), certain tyrosine kinase receptors (48), Wnt (73), and Hedgehog (78, 79).”
From Hypoxic control of metastasis (2016) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,654
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2002) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,624
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17771 · Cited by 1,106 · cited 4×
“Heterodimerization with HIF-1b is required for upregulation of genes by HIF-1a and HIF-2a (14, 15).”
BackgroundInfluentialHypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 850
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30117 · Cited by 596
Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R. Y., Housset, C., & Rosmorduc, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32524 · Cited by 483
The role of TGFβ1 in initiating hepatic stellate cell activation in vivo
Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., & Brenner, D. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80010-5 · Cited by 393
Cited by
Sorted by citations
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A. L., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3449 · Cited by 818
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras‐Raballand, A., Cohen, R., Cros, J. F., Faivre, S. J., Raymond, É., & Gramont, A. D. E. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 631
HIF ‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2015) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 588
Cancer stem cells versus phenotype‐switching in melanoma
Hoek, K. S., & Goding, C. R. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00757.x · Cited by 532
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Wei, X., Chen, Y., Jiang, X., Miao, P., Liu, Y., Mo, Y., Ren, D., Hua, Y., Yu, B., Zhou, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01288-1 · Cited by 477
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 430
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Fabregat, I., & Caballero‐Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 359
Multilayer control of the EMT master regulators
Zheng, H., & Kang, Y. (2013) · Oncogene · doi:10.1038/onc.2013.128 · Cited by 348
Pathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Tam, S. Y., Wu, V., & Law, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 319
Zhang, L., Huang, G., Li, X., Zhang, Y., Jiang, Y., Shen, J., Liu, J., Wang, Q., Zhu, J., Feng, X., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-108 · Cited by 303
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 271
Cancer drug resistance induced by EMT: novel therapeutic strategies
Rivas, J. D. L., Brozović, A., Izraely, S., Casas-Pais, A., Witz, I. P., & Figueroa, A. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03063-7 · Cited by 236
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Aravalli, R. N., Cressman, E. N. K., & Steer, C. J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0931-2 · Cited by 229
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Saxena, K., Jolly, M. K., & Balamurugan, K. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100845 · Cited by 205
Hypoxia and HIF Signaling: One Axis with Divergent Effects
Corrado, C., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165611 · Cited by 184
Severi, T., van Malenstein, H., Verslype, C., & van Pelt, J. F. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.142 · Cited by 182
Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., Yang, Y., Chen, X., & Liu, G. (2012) · Toxicology · doi:10.1016/j.tox.2012.09.017 · Cited by 164
Weeraratne, S. D., Amani, V. M., Teider, N., Francois, J. P., Winter, D., Kye, M. J., Sengupta, S., Archer, T. C., Remke, M., Bai, A. H. C., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0969-5 · Cited by 165
Olson, N. C., & van der Vliet, A. (2011) · Nitric Oxide · doi:10.1016/j.niox.2010.12.010 · Cited by 161
Glaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 169
Kahlert, C., Lahes, S., Radhakrishnan, P., Dutta, S., Mogler, C., Herpel, E., Brand, K., Steinert, G., Schneider, M. A., Mollenhauer, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2816 · Cited by 152
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
Neuzillet, C., Gramont, A. D. E., Tijeras‐Raballand, A., de Mestier, L., Cros, J. F., Faivre, S. J., & Raymond, É. (2013) · Oncotarget · doi:10.18632/oncotarget.1569 · Cited by 153
Csák, T., Bala, S., Lippai, D., Satishchandran, A., Catalano, D., Kodys, K., & Szabó, G. (2014) · Liver International · doi:10.1111/liv.12633 · Cited by 130
Xu, M., Pang, Q., Shengquan, X., Ye, C., Lei, R. L., Shen, Y., & Xu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.23225 · Cited by 132
ROS and oncogenesis with special reference to EMT and stemness
Chatterjee, R., & Chatterjee, J. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151073 · Cited by 129
Hepatocyte-Derived Snail1 Propagates Liver Fibrosis Progression
Rowe, R. G., Lin, Y., Shimizu‐Hirota, R., Hanada, S., Neilson, E. G., Greenson, J. K., & Weiss, S. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-10 · Cited by 131
The roles and mechanisms of hypoxia in liver fibrosis
Cai, J., Hu, M., Chen, Z., & Ling, Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02854-x · Cited by 136
Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species
Ju, S., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Choe, W., Yoon, K., Yeo, S. G., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212387 · Cited by 135
Zhou, P., Lessa, N. C., Estrada, D. K., Severson, E. B., Lingala, S., Zern, M. Α., Nolta, J. A., & Wu, J. (2011) · Liver Transplantation · doi:10.1002/lt.22270 · Cited by 108
Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy
Ma, Z., Wang, L. Z., Cheng, J.-T., Lam, S. T., Ma, X., Xiang, X., Wong, A. L., Goh, B. C., Gong, Q., Sethi, G., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7935 · Cited by 103
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
Matsuoka, J., Yashiro, M., Doi, Y., Fuyuhiro, Y., Kato, Y., Shinto, O., Noda, S., Kashiwagi, S., Aomatsu, N., Hirakawa, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062310 · Cited by 98
Sistigu, A., Modugno, F. D., Manic, G., & Nisticò, P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.008 · Cited by 100
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 94
Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis
Roth, K., & Copple, B. L. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.09.005 · Cited by 90
Self-citationZhao, B., Guan, H., Liu, J., Zheng, Z., Zhou, Q., Zhang, J., Su, L., & Hu, D. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2816 · Cited by 91
Han, W., Zhu, Q., Hu, J., Li, P., Zhang, F., & Li, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.029 · Cited by 82
The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition
Blackwell, R. H., Foreman, K. E., & Gupta, G. N. (2017) · Cancers · doi:10.3390/cancers9080105 · Cited by 84
The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
Mallikarjuna, P., Zhou, Y., & Landström, M. (2022) · Biomolecules · doi:10.3390/biom12050635 · Cited by 84
S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Tomčík, M., Palumbo‐Zerr, K., Zerr, P., Avouac, J., Dees, C., Šumová, B., Distler, A., Beyer, C., Cerezo, L. A., Bečvář, R., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204516 · Cited by 80
Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease
Gu, H., Han, S., & Park, K. (2020) · Toxins · doi:10.3390/toxins12030195 · Cited by 76
Kim, K., Kim, J., Back, J. H., Lee, J. E., & Ahn, D. (2022) · ACS Nano · doi:10.1021/acsnano.1c08508 · Cited by 77
Hepatocyte tissue factor activates the coagulation cascade in mice
Sullivan, B. P., Kopec, A. K., Joshi, N., Cline, H., Brown, J. A., Bishop, S., Kassel, K. M., Rockwell, C. E., Mackman, N., & Luyendyk, J. P. (2013) · Blood · doi:10.1182/blood-2012-09-455436 · Cited by 71
Zhou, J., Li, K., Gu, Y., Feng, B., Ren, G., Zhang, L., Yf, W., Nie, Y., & Fan, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.065 · Cited by 71
Park, J., Yoon, J., Lee, K. Y., & Park, B. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.015 · Cited by 68
RetractedZO Proteins and Redox-Dependent Processes
González‐Mariscal, L., Quirós, M., & Díaz-Coránguez, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3913 · Cited by 66
Li, H., Peng, C., Zhu, C., Nie, S., Qian, X., Shi, Z., Shi, M., Yan, L., Ding, X., Zhang, S., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01016-6 · Cited by 66
Huang, M., Wang, L., Chen, J., Bai, M., Zhou, C., Liu, S., & Lin, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3421 · Cited by 65
Sun, J., Shi, L., Xiao, T., Xue, J., Li, J., Wang, P., Wu, L. Y., Dai, X., Ni, X., & Liu, Q. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129177 · Cited by 63
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Huang, F., Santinon, F., González, R. E. F., & Rincon, S. V. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756001 · Cited by 66
Shi, Y., Wang, S., Zhang, W., Zhu, Y., Fan, Z., Huang, Y., Li, F., & Yang, R. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02996-9 · Cited by 64
Hypoxia pathway proteins and their impact on the blood vasculature
Rodriguez, D., Watts, D., Gaete, D., Sormendi, S., & Wielockx, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179191 · Cited by 62
Altemus, M., Goo, L., Little, A. C., Yates, J. A., Cheriyan, H., Wu, Z.-F., & Merajver, S. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220973 · Cited by 63
The Protective Effect of Bee Venom on Fibrosis Causing Inflammatory Diseases
Lee, W., Pak, S. C., & Park, K. (2015) · Toxins · doi:10.3390/toxins7114758 · Cited by 64
Kong, D., Zhang, F., Shao, J., Wu, L., Zhang, X., Chen, L., Lu, Y., & Zheng, S. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.107 · Cited by 62
Dubbelboer, I. R., Pavlovic, N., Heindryckx, F., Sjögren, E., & Lennernäs, H. (2019) · Cancers · doi:10.3390/cancers11071024 · Cited by 59
Hong, M., Shi, H., Wang, N., Tan, H., Wang, Q., & Feng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00696 · Cited by 59
Cui, Y., Li, Y., Li, J., Zhang, H., Wang, F., Bai, X., & Li, S. (2016) · Oncology Reports · doi:10.3892/or.2016.4822 · Cited by 57
Mallikarjuna, P., Sitaram, R. T., Aripaka, K., Ljungberg, B., & Landström, M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1642069 · Cited by 55
Kang, Y. B., Eo, J., Bulutoglu, B., Yarmush, M. L., & Usta, O. B. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27225 · Cited by 55
Page, L. K., Staples, K. J., Spalluto, C. M., Watson, A., & Wilkinson, T. M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653969 · Cited by 59
Tang, H., He, H., Ji, H. L., Gao, L., Mao, J., Liu, J., Lin, H., & Wu, T. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.02.062 · Cited by 53
Kim, M., Park, S.-A., Kim, C. H., Park, S.-Y., Kim, J.-S., Kim, D., Nam, J., & Sheen, Y. Y. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438651 · Cited by 54
Zhao, B., Guan, H., Liu, J.-Q., Zheng, Z., Zhou, Q., Zhang, J., Su, L., & Hu, D. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4403 · Cited by 12
Lee, W., Kim, K. H., An, H., Kim, J., Lee, S.-J., Han, S., Pak, S. C., & Park, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.089 · Cited by 49
Sesé, M., Fuentes, P. J. B., Esteve‐Codina, A., Béjar, E., McGrail, K., Thomas, G., Aasen, T., & y Cajal, S. R. (2017) · Oncotarget · doi:10.18632/oncotarget.23145 · Cited by 48
Mochizuki, A., Pace, A., Rockwell, C. E., Roth, K., Chow, A. K., O’Brien, K. M., Albee, R., Kelly, K. M., Towery, K., Luyendyk, J. P., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303195 · Cited by 48
Self-citationMKL1 is an epigenetic modulator of TGF-β induced fibrogenesis
Fan, Z., Hao, C., Li, M., Dai, X., Qin, H., Li, J., Xu, H., Wu, X., Zhang, L., Fang, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.013 · Cited by 47
Kim, J., An, H., Kim, W., Gwon, M., Gu, H., Park, Y.-Y., & Park, K. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.022 · Cited by 48
Hypoxic Microenvironment Induces EMT and Upgrades Stem-Like Properties of Gastric Cancer Cells
Guo, J., Wang, B., Fu, Z., Wei, J., & Lü, W. (2015) · Technology in Cancer Research & Treatment · doi:10.1177/1533034614566413 · Cited by 49
Bogaerts, E., Heindryckx, F., Vandewynckel, Y., van Grunsven, L. A., & Vlierberghe, H. V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2286 · Cited by 43
Cheng, S., Guo, J., Yang, Q., & Yang, X. (2015) · Medical Oncology · doi:10.1007/s12032-015-0494-1 · Cited by 42
Teng, Y., & Xu, L. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9621-6 · Cited by 44
Tan, Z., Wang, C., Li, X., & Guan, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00210 · Cited by 42
Suflețel, R. T., Melincovici, C. S., Gheban, B., Zaharie, T., & Mihu, C. M. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.01 · Cited by 44
Zhang, Z., Xu, Y., Cao, C. Q., Wang, B., Guo, J., Qin, Z., Lu, Y., Zhang, J., Zhang, L., Wang, W., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17162 · Cited by 43
HIF-1α Promotes Breast Cancer Cell MCF-7 Proliferation and Invasion Through Regulating miR-210
Zhang, Y., Yan, J., Wang, L., Dai, H., Li, N., Hu, W., & Cai, H. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2270 · Cited by 37
Chatterjee, R., Ghosh, B., Mandal, M., Nawn, D., Banerjee, S., Pal, M., Paul, R. R., Banerjee, S., & Chatterjee, J. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151146 · Cited by 36
Meng, Z., Zhang, X., Tan, H., & Lian, H. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134781 · Cited by 35
Qian, F., He, M., Duan, W., Mao, L., Li, Q., Yu, Z., Zhou, Z., & Zhang, Y. (2015) · PubMed · Cited by 32
Ahuja, S., & Zaheer, S. (2023) · Cell Biology International · doi:10.1002/cbin.12097 · Cited by 33
Chavan, H. D., & Krishnamurthy, P. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371476 · Cited by 32
Liu, N., WANG, Y., Zhou, Y., Pang, H., Zhou, J., QIAN, P., Liu, L., & Zhang, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3495 · Cited by 30
Hung, C.-L., Yen, C.-S., Tsai, H.-W., Su, Y., & Yen, C.-J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1671-5 · Cited by 29
Cheng, S., Lin, H. L., Guo, J., Yang, Q., Zhou, J., & Yang, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2540-6 · Cited by 28
Hepatic Stellate Cells in Liver Tumor
Shiraha, H., Iwamuro, M., & Okada, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_4 · Cited by 27
Onishi, H., Morisaki, T., Nakao, F., Odate, S., Morisaki, T., & Katano, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.041 · Cited by 26
Strickland, J. D., Garrison, D., & Copple, B. L. (2020) · Cytokine · doi:10.1016/j.cyto.2020.154986 · Cited by 28
Self-citationNahomi, R. B., & Nagaraj, R. H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26877 · Cited by 26
Banerjee, A., & Farci, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168641 · Cited by 25
Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat
Xie, H., Tan, J., Wang, R., Meng, X., Xue Ming, T. A. N. G., & Gao, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498978 · Cited by 23
HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats
Moczydłowska, J. M., Miltyk, W., Hermanowicz, A., Lebensztejn, D. M., Palka, J. A., & Dębek, W. (2016) · Journal of Investigative Surgery · doi:10.1080/08941939.2016.1183734 · Cited by 23
Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
Scherbakov, A. M., Стефанова, Л. Б., Sorokin, D. V., Semina, S. E., Berstein, L. M., & Ma, K. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.08.019 · Cited by 22
Inhibition of Survivin Reduces HIF-1α, TGF-β1 and TFE3 in Salivary Adenoid Cystic Carcinoma
Wang, Y., Ma, S., Wang, W., Huang, C., Zhao, Z., Liu, B., Zhang, W., Zhao, Y., Zhang, L., & Sun, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114051 · Cited by 21
Tao, J., Barnett, J. V., Watanabe, M., & Ramírez‐Bergeron, D. L. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5020019 · Cited by 21
Spliced XBP1 Rescues Renal Interstitial Inflammation Due to Loss of Sec63 in Collecting Ducts
Ishikawa, Y., Fedeles, S. V., Marlier, A., Zhang, C., Gallagher, A., Lee, A.-H., & Somlo, S. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060614 · Cited by 21
Pal, A., Ashworth, J., Collier, P., Probert, C., Jones, S. J., Leza, E. P., Meakin, M. L., Ritchie, A., Onion, D., Clarke, P. A., et al. (2020) · Cancers · doi:10.3390/cancers12082290 · Cited by 19
Forces at play: exploring factors affecting the cancer metastasis
Riaz, F., Zhang, J., & Pan, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1274474 · Cited by 23
Cai, Z., Li, H., Zhang, H., Han, S., AN, R., & Yan, X. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1595 · Cited by 20
Metadata
- Authors
- Copple, B. L.
- Affiliations
- University of Kansas Medical Center (US)
- Corresponding author
- Copple, Bryan L.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2010-05
- Volume
- 30
- Issue
- 5
- Pages
- 669-682
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- PMC
- PMC3111074
- OpenAlex
- W2039775393
- Cited by
- 164
- References
- 30
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 16 · 2021: 16 · 2020: 13 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 10 · 2015: 16 · 2014: 11 · 2013: 16 · 2012: 8
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Liver International (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (DK073566, R01DK073566)
- National Center for Research Resources (P20RR021940, P20RR016475)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- hypoxia, epithelial-mesenchymal transition, hepatocytes, hypoxia-inducible factor-1α, TGF-beta, liver fibrosis, myofibroblast differentiation, bile duct ligation, alpha-smooth muscle actin, snails, S100A4, TGF-β receptor inhibition
- MeSH terms
- S100 Calcium-Binding Protein A4, Actins, Animals, Calcium-Binding Proteins, Epithelial Cells, Membrane Proteins, Mesoderm, Mice, Inbred C57BL, S100 Proteins, Phosphoproteins, Cell Hypoxia, Cadherins, Hepatocytes, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Keratin-19, Transforming Growth Factor beta1, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review